Ken Griffin Glaukos Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Glaukos Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 21,600 shares of GKOS stock, worth $2.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,600
Previous 44,500
51.46%
Holding current value
$2.81 Million
Previous $4.2 Million
39.07%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$709 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$247 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$241 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$210 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.19B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...